Patrick James Orme

Array ( [id] => 4699132 [patent_doc_number] => 20080221316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'siRNA targeting ethanolamine Kinase I1 (EKI1)' [patent_app_type] => utility [patent_app_number] => 11/810381 [patent_app_country] => US [patent_app_date] => 2007-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 34738 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20080221316.pdf [firstpage_image] =>[orig_patent_app_number] => 11810381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6597724 [patent_doc_number] => 20100048673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'OLIGONUCLEOTIDES AFFECTING EXPRESSION OF PHOSPHODIESTERASES' [patent_app_type] => utility [patent_app_number] => 12/301442 [patent_app_country] => US [patent_app_date] => 2007-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18041 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048673.pdf [firstpage_image] =>[orig_patent_app_number] => 12301442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6597724 [patent_doc_number] => 20100048673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'OLIGONUCLEOTIDES AFFECTING EXPRESSION OF PHOSPHODIESTERASES' [patent_app_type] => utility [patent_app_number] => 12/301442 [patent_app_country] => US [patent_app_date] => 2007-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18041 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048673.pdf [firstpage_image] =>[orig_patent_app_number] => 12301442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10001682 [patent_doc_number] => 09045754 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-02 [patent_title] => 'Short antisense compounds with gapmer configuration' [patent_app_type] => utility [patent_app_number] => 11/745429 [patent_app_country] => US [patent_app_date] => 2007-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 137530 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11745429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5465842 [patent_doc_number] => 20090326042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF CRP' [patent_app_type] => utility [patent_app_number] => 12/299768 [patent_app_country] => US [patent_app_date] => 2007-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 137522 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0326/20090326042.pdf [firstpage_image] =>[orig_patent_app_number] => 12299768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5016621 [patent_doc_number] => 20070259830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Antisense Agents Combining Strongly Bound Base-Modified Oligonucleotide and Artificial Nuclease' [patent_app_type] => utility [patent_app_number] => 11/742384 [patent_app_country] => US [patent_app_date] => 2007-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19074 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20070259830.pdf [firstpage_image] =>[orig_patent_app_number] => 11742384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4734359 [patent_doc_number] => 20080051339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'Modulators of pharmacological agents' [patent_app_type] => utility [patent_app_number] => 11/789992 [patent_app_country] => US [patent_app_date] => 2007-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 32284 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20080051339.pdf [firstpage_image] =>[orig_patent_app_number] => 11789992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8527828 [patent_doc_number] => 08304398 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-06 [patent_title] => 'Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly or abnormally expressed gene' [patent_app_type] => utility [patent_app_number] => 12/297251 [patent_app_country] => US [patent_app_date] => 2007-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15618 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12297251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4670414 [patent_doc_number] => 20080045474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Method for treatment of invasive cells' [patent_app_type] => utility [patent_app_number] => 11/785721 [patent_app_country] => US [patent_app_date] => 2007-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5125 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045474.pdf [firstpage_image] =>[orig_patent_app_number] => 11785721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7535237 [patent_doc_number] => 08048863 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-01 [patent_title] => 'RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions' [patent_app_type] => utility [patent_app_number] => 12/296621 [patent_app_country] => US [patent_app_date] => 2007-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11856 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/048/08048863.pdf [firstpage_image] =>[orig_patent_app_number] => 12296621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5479666 [patent_doc_number] => 20090202623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'GENE THERAPY FOR CANCER USING SMALL INTERFERING RNA SPECIFIC TO ANT2 AND A METHOD TO OVERCOME TOLERANCE TO ANTITUMOR AGENT' [patent_app_type] => utility [patent_app_number] => 12/293416 [patent_app_country] => US [patent_app_date] => 2007-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 6847 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202623.pdf [firstpage_image] =>[orig_patent_app_number] => 12293416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5198667 [patent_doc_number] => 20070297985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'METHOD AND COMPOSITION FOR ENHANCING BONE FORMATION' [patent_app_type] => utility [patent_app_number] => 11/733615 [patent_app_country] => US [patent_app_date] => 2007-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11341 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20070297985.pdf [firstpage_image] =>[orig_patent_app_number] => 11733615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6430157 [patent_doc_number] => 20100168534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'BLOOD INSPECTION DEVICE' [patent_app_type] => utility [patent_app_number] => 12/293624 [patent_app_country] => US [patent_app_date] => 2007-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 28747 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168534.pdf [firstpage_image] =>[orig_patent_app_number] => 12293624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6566695 [patent_doc_number] => 20100234287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'Targeting Bacterial Suicide Pathways for the Development of Novel Antibiotics' [patent_app_type] => utility [patent_app_number] => 12/293838 [patent_app_country] => US [patent_app_date] => 2007-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 17426 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234287.pdf [firstpage_image] =>[orig_patent_app_number] => 12293838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 43987 [patent_doc_number] => 07776835 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-17 [patent_title] => 'Trans-excision-splicing ribozyme and methods of use' [patent_app_type] => utility [patent_app_number] => 11/723456 [patent_app_country] => US [patent_app_date] => 2007-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 17 [patent_no_of_words] => 10050 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/776/07776835.pdf [firstpage_image] =>[orig_patent_app_number] => 11723456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4939409 [patent_doc_number] => 20080076728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Novel method of protecting islet cells from apoptosis during the donor harvesting process' [patent_app_type] => utility [patent_app_number] => 11/725470 [patent_app_country] => US [patent_app_date] => 2007-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 2497 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076728.pdf [firstpage_image] =>[orig_patent_app_number] => 11725470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8549475 [patent_doc_number] => 08324357 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'Universal fieldable assay with unassisted visual detection' [patent_app_type] => utility [patent_app_number] => 11/682796 [patent_app_country] => US [patent_app_date] => 2007-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6618 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11682796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7724371 [patent_doc_number] => 08097642 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-17 [patent_title] => 'Therapeutic inhibitor of vascular smooth muscle cells' [patent_app_type] => utility [patent_app_number] => 11/679650 [patent_app_country] => US [patent_app_date] => 2007-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 27 [patent_no_of_words] => 34518 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/097/08097642.pdf [firstpage_image] =>[orig_patent_app_number] => 11679650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10892918 [patent_doc_number] => 08916529 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-23 [patent_title] => 'Oligonucleotide-containing pharmacological compositions and their use' [patent_app_type] => utility [patent_app_number] => 11/673486 [patent_app_country] => US [patent_app_date] => 2007-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19270 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11673486 [rel_patent_id] =>[rel_patent_doc_number] =>)